Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Before or After Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
2007-005977-67Phase 2Completed
- Sponsor
- Consorzio Oncotech
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sunitinib in metastatic renal cell carcinoma (mRCC) (2 arms), sponsored by Consorzio Oncotech. Started Feb 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2007-005977-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005977-67.